Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Panikar

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of the Association of Physicians of India|June 22, 2012
Pioglitazone and bladder cancer: the pros and consVijay Panikar
The Journal of the Association of Physicians of India|September 12, 2007
Induction of long-term glycemic control in type 2 diabetic patients using pioglitazone and metformin combinationVijay Panikar, Shashank R Joshi, A Bukkawar, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 12, 2020
Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)Sujoy Ghosh, Mangesh Tiwaskar, Rajiv Chawla, et al.
The Journal of the Association of Physicians of India|July 21, 2004
Beneficial effects of triple drug combination of pioglitazone with glibenclamide and metformin in type 2 diabetes mellitus patients on insulin therapyVijay Panikar, H B Chandalia, Shashank R Joshi, et al.
The Journal of the Association of Physicians of India|June 15, 2018
Effect of Low (7.5 mg/day), Standard (15 mg/ day) and High (30 mg/day) Dose Pioglitazone Therapy on Glycemic Control and Weight Gain in Recently-Diagnosed Type 2 Diabetes PatientsVijay Panikar, Namdev J Kale, Sumedh S Hoskote, et al.
The Journal of the Association of Physicians of India|July 18, 2019
Autoimmune Hypoglycemia Relapse on Glucocorticoids, Effectively Treated with AzathioprineVijay Panikar, Shashank Joshi, Jimit Vadgama, et al.
The Journal of the Association of Physicians of India|July 19, 2019
Efficacy of SGLT2 Inhibitors as the Fifth Drug in the Management of Type 2 Diabetes Mellitus in Asian Indians not Controlled with at least 4 Oral Antidiabetic DrugsVijay Panikar, Shashank R Joshi, Narayan Deogaonkar, et al.
The Journal of the Association of Physicians of India|March 7, 2009
Prevalence of metabolic syndrome in an urban Indian diabetic population using the NCEP ATP III guidelinesS P Surana, D B Shah, K Gala, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Evolution of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Asian-Indian Patients Over the Last 15 Years using Adult Treatment Panel III of the National Cholesterol Education Program, World Health Organization, and International Diabetes Federation CriterionHarshpreet Singh Tuteja, Nikhil Nassikar, Krish Panikar, et al.
The Journal of the Association of Physicians of India|July 14, 2022
Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes MellitusVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of the Association of Physicians of India|June 22, 2012
Pioglitazone and bladder cancer: the pros and consVijay Panikar
The Journal of the Association of Physicians of India|September 12, 2007
Induction of long-term glycemic control in type 2 diabetic patients using pioglitazone and metformin combinationVijay Panikar, Shashank R Joshi, A Bukkawar, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 12, 2020
Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)Sujoy Ghosh, Mangesh Tiwaskar, Rajiv Chawla, et al.
The Journal of the Association of Physicians of India|July 21, 2004
Beneficial effects of triple drug combination of pioglitazone with glibenclamide and metformin in type 2 diabetes mellitus patients on insulin therapyVijay Panikar, H B Chandalia, Shashank R Joshi, et al.
The Journal of the Association of Physicians of India|June 15, 2018
Effect of Low (7.5 mg/day), Standard (15 mg/ day) and High (30 mg/day) Dose Pioglitazone Therapy on Glycemic Control and Weight Gain in Recently-Diagnosed Type 2 Diabetes PatientsVijay Panikar, Namdev J Kale, Sumedh S Hoskote, et al.
The Journal of the Association of Physicians of India|July 18, 2019
Autoimmune Hypoglycemia Relapse on Glucocorticoids, Effectively Treated with AzathioprineVijay Panikar, Shashank Joshi, Jimit Vadgama, et al.
The Journal of the Association of Physicians of India|July 19, 2019
Efficacy of SGLT2 Inhibitors as the Fifth Drug in the Management of Type 2 Diabetes Mellitus in Asian Indians not Controlled with at least 4 Oral Antidiabetic DrugsVijay Panikar, Shashank R Joshi, Narayan Deogaonkar, et al.
The Journal of the Association of Physicians of India|March 7, 2009
Prevalence of metabolic syndrome in an urban Indian diabetic population using the NCEP ATP III guidelinesS P Surana, D B Shah, K Gala, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Evolution of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Asian-Indian Patients Over the Last 15 Years using Adult Treatment Panel III of the National Cholesterol Education Program, World Health Organization, and International Diabetes Federation CriterionHarshpreet Singh Tuteja, Nikhil Nassikar, Krish Panikar, et al.
The Journal of the Association of Physicians of India|July 14, 2022
Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes MellitusVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
Pageof 2